When a company raises its future financial guidance, it often indicates stronger than expected performance and growth prospects. This typically leads to increased investor confidence and can drive the stock price up in the short term. Given that TransMedics has directly raised its 2024 guidance, this is a clear positive signal to the market, likely resulting in the observed uptick in share price.